Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
171.2 INR | -0.61% |
|
-4.63% | +0.20% |
06-28 | Dishman Carbogen Amcis Receives FDA Clearance for Swiss Manufacturing Facilities | MT |
05-31 | Transcript : Dishman Carbogen Amcis Limited, Q4 2024 Earnings Call, May 31, 2024 |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
809B | ||||||
624B | ||||||
351B | - | - | - | - | ||
319B | ||||||
289B |